Literature DB >> 21260945

miR-31 in cancer: location matters.

Christina H Stuelten, David S Salomon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21260945     DOI: 10.4161/cc.9.23.13928

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  5 in total

1.  The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis.

Authors:  Rom S Leidner; Lakshmeswari Ravi; Patrick Leahy; Yanwen Chen; Beth Bednarchik; Mirte Streppel; Marcia Canto; Jean S Wang; Anirban Maitra; Joseph Willis; Sanford D Markowitz; Jill Barnholtz-Sloan; Mark D Adams; Amitabh Chak; Kishore Guda
Journal:  Genes Chromosomes Cancer       Date:  2012-02-03       Impact factor: 5.006

2.  microRNA-31 modulates skeletal patterning in the sea urchin embryo.

Authors:  Nadezda A Stepicheva; Jia L Song
Journal:  Development       Date:  2015-09-23       Impact factor: 6.868

3.  Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Authors:  Lene Rask; Eva Balslev; Rolf Søkilde; Estrid Høgdall; Henrik Flyger; Jens Eriksen; Thomas Litman
Journal:  Cell Oncol (Dordr)       Date:  2014-07-16       Impact factor: 6.730

4.  miR-155 and miR-31 are differentially expressed in breast cancer patients and are correlated with the estrogen receptor and progesterone receptor status.

Authors:  Zhenduo Lu; Yuping Ye; Dechuang Jiao; Jianhua Qiao; Shude Cui; Zhenzhen Liu
Journal:  Oncol Lett       Date:  2012-08-03       Impact factor: 2.967

5.  Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.

Authors:  Hui Chen; Chuanli Ren; Chongxu Han; Daxin Wang; Yong Chen; Deyuan Fu
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.